Lifespan Cancer Institute at Rhode Island Hospital — Providence, Rhode Island

Lifespan Cancer Institute at Rhode Island Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute at Rhode Island Hospital has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma.

Sponsors: Numab Therapeutics AG, Dana-Farber Cancer Institute, Precision BioSciences, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute at Rhode Island Hospital?

Lifespan Cancer Institute at Rhode Island Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute at Rhode Island Hospital conducted?

Lifespan Cancer Institute at Rhode Island Hospital has 5 clinical trials on record, with 1 currently active. Their work covers Ovarian Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma.

Is Lifespan Cancer Institute at Rhode Island Hospital accredited by Crixeo Health?

Yes — Lifespan Cancer Institute at Rhode Island Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lifespan Cancer Institute at Rhode Island Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.